, 2017 Desquamative gingivitis (DG) is characterized by erythematous, epithelial desquamation, erosion of the gingival epithelium, and blister formation on the gingiva. DG is a clinical feature of a variety of diseases or disorders.
Doi, Kenji +9 more
core +2 more sources
Analgesic effects of platelet‐rich fibrin (PRF): A systematic review
Periodontology 2000, EarlyView.Abstract Background Platelet‐rich fibrin (PRF), a second‐generation autologous platelet concentrate, has gained significant interest for its anti‐inflammatory and regenerative characteristics. While its role in tissue healing is well‐recognized, the analgesic potential of PRF remains under‐investigated.
Nathan E. Estrin +6 more
wiley +1 more source
Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation [PDF]
, 2004 Plectin is one of the largest and most versatile cytolinker proteins known. Cloned and sequenced in 1991, it was later shown to have nonsense mutations in recessive epidermolysis bullosa with muscular dystrophy.
De Groot, WP +7 more
core +1 more source
Systemic disease or periodontal disease? Distinguishing causes of gingival inflammation: a guide for dental practicioners:PART I: immune mediated, autoinflammatory, and hereditary lesions [PDF]
, 2019 Periodontitis and gingivitis remain two of the most common diseases that affect the oral cavity. As they are caused by plaque, effective oral hygiene, elimination of plaque-retentive factors and successful periodontal treatment will result in resolution ...
Blair, Fiona +5 more
core +1 more source
JAK Inhibitors as a Novel Approach to Autoimmune Bullous Diseases: A Review
Dermatologic Therapy, Volume 2026, Issue 1, 2026.Autoimmune bullous diseases (AIBDs) are a group of chronic disorders characterized by blister formation resulting from abnormal immune responses. Janus kinase (JAK) inhibitors have emerged as promising therapeutic agents for AIBDs. This review discusses the use of JAK inhibitors—such as upadacitinib, baricitinib, tofacitinib, and abrocitinib, among ...
Olga Olisova +9 more
wiley +1 more source
A Case of Oropharyngeal Bullous Pemphigoid Presenting with Haemoptysis [PDF]
, 2015 Objective. Bullous pemphigoid is well known for its cutaneous features; however in rare cases it may present with mucosal involvement. We report a case of bullous pemphigoid presenting with haemoptysis, initially presenting to the Ear, Nose and Throat ...
C. M. Lee +2 more
core +2 more sources
The Current State of Clinical Diagnostic Algorithms for Mucosal Oral Lesions: A Scoping Review
Oral Diseases, Volume 31, Issue 11, Page 3023-3033, November 2025.ABSTRACT Background Diagnosing oral lesions remains challenging for many dentists. Despite the availability of diagnostic algorithms, there is a dearth of comprehensive evidence synthesis and a discussion on their clinical and pedagogical applicability.
Mohammed Al‐Shehri +7 more
wiley +1 more source
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease [PDF]
, 2022 Importance: Ecthyma contagiosum, or orf, is a viral zoonotic infection caused by Poxviridae. Although human orf infection is considered to follow a self-limited course, various immunological reactions may be triggered, including immunobullous diseases ...
Blauvelt, Andrew +11 more
core +1 more source
Mucous Membrane Pemphigoid with Ocular Involvement:The Clinical Phenotype and Its Relationship to Direct Immunofluorescence Findings [PDF]
, 2018 PurposeThis study explored the validity of the First International Consensus on Mucous Membrane Pemphigoid (MMP) guidance, which recommends that clinically indistinguishable patients, who have direct immunofluorescence (DIF)-negative biopsies, be ...
, +4 more
core +4 more sources
, 2006 DERMATOLOGYSKIN DISEASESКОЖНЫЕ БОЛЕЗНИМЕТОДИЧЕСКИЕ РЕКОМЕНДАЦИИПРАКТИЧЕСКАЯ ДЕРМАТОЛОГИЯRecommendations include tests, clinical tasks and practical skills in dermatology that are used as during practical classes as at the ...
Adaskevich, V. P. +2 more
core